In addition, the Laboratory  may be required by WADA  to analyze additional EQAS  samples and/or to review the analytical results and to re -analyze any relevant  and available  Samples previously reported as Adverse Analytical Findings 25 during the preceding twelve (12) months  (or during a period otherwise determined by WADA ), within seven (7) days (unless informed otherwise by WADA ).